Tech Company Financing Transactions
arcoris bio Funding Round
arcoris bio closed a $7.8 million Seed funding round on 11/6/2025. Investors included ZEISS Group, private investors and Zürcher Kantonalbank.
Transaction Overview
Company Name
Announced On
11/6/2025
Transaction Type
Venture Equity
Amount
$7,800,000
Round
Seed
Investors
ZEISS Group (Lead Investor)
Proceeds Purpose
The company intends to use the funds to accelerate industrialization of the MUSE platform, expansion of strategic partnerships, and launch of new products.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
Undisclosed
Schlieren, Undisclosed
Switzerland
Schlieren, Undisclosed
Switzerland
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Our mission: A world where multiplex biomarkers enable precise diagnosis and personalized treatment for every patient. Our vision: To build a leading company advancing biomarker detection with precise, accessible, and ethical solutions for researchers and clinicians.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Matyas Vegh
Browse more venture capital transactions:
Prev: 11/6/2025: Arx Research venture capital transaction
Next: 11/6/2025: Ripple venture capital transaction
Share this article
Where The Data Comes From
We do our best to document tech company VC transactions. All VC database entries reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs